- Home
- FIG vs KVUE Comparison
FIG vs KVUE Comparison
Compare FIG & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIG
- KVUE
- Stock Information
- Founded
- FIG 2012
- KVUE 2022
- Country
- FIG United States
- KVUE United States
- Employees
- FIG N/A
- KVUE N/A
- Industry
- FIG Computer Software: Prepackaged Software
- KVUE Specialty Chemicals
- Sector
- FIG Technology
- KVUE Consumer Discretionary
- Exchange
- FIG Nasdaq
- KVUE Nasdaq
- Market Cap
- FIG 34.1B
- KVUE 39.9B
- IPO Year
- FIG 2025
- KVUE 2023
- Fundamental
- Price
- FIG $53.22
- KVUE $14.99
- Analyst Decision
- FIG Hold
- KVUE Buy
- Analyst Count
- FIG 9
- KVUE 12
- Target Price
- FIG $69.71
- KVUE $20.92
- AVG Volume (30 Days)
- FIG 11.6M
- KVUE 31.6M
- Earning Date
- FIG 11-05-2025
- KVUE 11-07-2025
- Dividend Yield
- FIG N/A
- KVUE 5.53%
- EPS Growth
- FIG N/A
- KVUE 28.77
- EPS
- FIG 0.48
- KVUE 0.74
- Revenue
- FIG $893,423,000.00
- KVUE $15,141,000,000.00
- Revenue This Year
- FIG $38.32
- KVUE N/A
- Revenue Next Year
- FIG $22.78
- KVUE $3.10
- P/E Ratio
- FIG $111.17
- KVUE $20.27
- Revenue Growth
- FIG 48.36
- KVUE N/A
- 52 Week Low
- FIG $49.53
- KVUE $14.05
- 52 Week High
- FIG $142.92
- KVUE $25.17
- Technical
- Relative Strength Index (RSI)
- FIG N/A
- KVUE 35.75
- Support Level
- FIG N/A
- KVUE $14.81
- Resistance Level
- FIG N/A
- KVUE $15.54
- Average True Range (ATR)
- FIG 0.00
- KVUE 0.67
- MACD
- FIG 0.00
- KVUE 0.07
- Stochastic Oscillator
- FIG 0.00
- KVUE 31.77
About FIG Figma Inc.
Figma Inc is engaged in transforming ideas into digital products and experiences. The group focuses on the entire software creation lifecycle, enabling it to quickly launch new products on Figma's browser-based platform and reinforcing its belief that design extends well beyond a single step or role. The company adopts an expansive view, as design is more than how something looks, feels, or works. It derives its revenue from sales of subscriptions for access to its platform.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.